Your browser doesn't support javascript.
loading
Identification of a novel HLA-A 02:01-restricted cytotoxic T lymphocyte epitope derived from the EML4-ALK fusion gene.
Yoshimura, Mayuko; Tada, Yoshitaka; Ofuzi, Kazuya; Yamamoto, Masakazu; Nakatsura, Tetsuya.
Afiliação
  • Yoshimura M; Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Chiba 277-8577, Japan.
  • Tada Y; Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Chiba 277-8577, Japan.
  • Ofuzi K; Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Chiba 277-8577, Japan.
  • Yamamoto M; Department of Gastroenterological Surgery, Tokyo Women's Medical University, Shinzyukuku, Tokyo 162-8666, Japan.
  • Nakatsura T; Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Chiba 277-8577, Japan.
Oncol Rep ; 32(1): 33-9, 2014 Jul.
Article em En | MEDLINE | ID: mdl-24842630
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeos / Linfócitos T Citotóxicos / Antígeno HLA-A2 / Proteínas de Fusão Oncogênica / Antígeno HLA-A24 / Imunoterapia / Neoplasias Pulmonares / Antígenos de Neoplasias Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeos / Linfócitos T Citotóxicos / Antígeno HLA-A2 / Proteínas de Fusão Oncogênica / Antígeno HLA-A24 / Imunoterapia / Neoplasias Pulmonares / Antígenos de Neoplasias Idioma: En Ano de publicação: 2014 Tipo de documento: Article